Research and Development

We endeavor to stay at the cutting edge of organ transplant surveillance solutions by continuously exploring and developing new clinically relevant approaches to our products. Our ongoing research and development efforts include:

  1. Further refinement of the AlloMap product line
  2. Undertaking additional studies to expand the clinical utility of AlloMap and generate additional data to enhance clinical understanding of transplant rejection
  3. New product development in other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection
  4. Technology platform development to increase efficiency and lower costs in our testing and laboratory operations

I confirm that I am not in the following jurisdictions:

Australia, Hong Kong, Japan, Canada, New Zealand or South Africa and am able to receive the following report and documents.